Aging Vitamin E, and Immune Function in Aged

维生素E的老化与老年人的免疫功能

基本信息

  • 批准号:
    6720856
  • 负责人:
  • 金额:
    $ 28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-09-30 至 2008-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Aging is associated with a decline in T cell mediated functions, which contributes to a higher incidence of, and morbidity and mortality from, infectious diseases and tumors. The age-related defect in T cells has been shown to be due to intrinsic declines in T cell function, as well as increased production of prostaglandin (PG)E2, a T cell suppressive factor, by macrophages (Mphi). We demonstrated that the increased PGE2 production was due to ceramide mediated upregulation of cyclooxygenase 2 (COX-2) transcription, a key regulatory enzyme in PGE2 synthesis. The signaling mechanism through which ceramide upregulates COX 2 expression, however, is not known and needs to be investigated. We further showed that vitamin E (E) supplementation improves T cell mediated function by two distinct mechanisms: a) by decreasing PGE2 production, thus reducing macrophage Mphi mediated suppression, and b) by directly enhancing T cell function, independent of its effect on Mphi PGE2 production. E exerts its effect by improving the ability of naive T cells from old mice to produce IL-2 and progress through cell division cycles. The mechanism of E-induced enhancement of naive T cell function is not known and needs to be determined. Thus, the specific aims of this proposal are: 1) To determine the signaling pathway involved in ceramide-induced upregulation of COX-2 expression in old Mphi. To accomplish this goal, we will test the hypothesis that ceramide upregulates COX-2 expression in old macrophages through enhancing PKC-zeta activity, leading to increased IkappaB phosphorylation, and thus degradation. This in turn will increase NFkappaB activation and COX-2 expression. 2) To determine the mechanism of E-induced increase in the function of old naive T cells. To accomplish this goal, we will test the hypothesis that E enhances naive T cell function in old mice by increasing their ability to form an effective immune synapse at the site of T cell receptor (TCR) and antigen contact. This, in turn, will lead to improved TCR-associated signal transduction, and subsequent, IL-2 production in old mice. We propose that E induces its effect by changing the redistribution of key TCR associated signaling molecules in membrane lipid domains, known as lipid rafts, by one or both of the following mechanisms: a) increasing palmitoylation of key signaling molecules associated with TCR-mediated activation, and b) changing the structure of the lipid component of lipid rafts. These experiments will elucidate the mechanism of the age-related dysregulation of macrophages and T cells, as well as their normalization by E. This, in turn, will help in designing practical nutritional interventions to reverse and/or delay the age-associated dysregulation of immune and inflammatory responses as well as diseases associated with it.
描述(由申请人提供):衰老与T细胞介导的功能下降有关,这导致感染性疾病和肿瘤的发病率、发病率和死亡率较高。T细胞中与年龄相关的缺陷已被证明是由于T细胞功能的内在下降,以及巨噬细胞(Mphi)产生的T细胞抑制因子前列腺素(PG)E2的增加。我们证明,增加PGE 2的生产是由于神经酰胺介导的上调环氧合酶2(考克斯-2)的转录,在PGE 2合成的关键调控酶。然而,神经酰胺上调考克斯2表达的信号机制尚不清楚,需要进一步研究。我们进一步表明,维生素E(E)补充通过两种不同的机制改善T细胞介导的功能:a)通过减少PGE 2产生,从而减少巨噬细胞Mphi介导的抑制,和B)通过直接增强T细胞功能,而不依赖于其对Mphi PGE 2产生的影响。E通过提高来自老年小鼠的幼稚T细胞产生IL-2的能力并通过细胞分裂周期进行发挥其作用。E诱导的初始T细胞功能增强的机制尚不清楚,需要确定。因此,这项建议的具体目标是: 1)确定神经酰胺诱导老年Mphi中考克斯-2表达上调的信号通路。为了实现这一目标,我们将检验神经酰胺通过增强PKC-zeta活性上调老年巨噬细胞中考克斯-2表达,导致IkappaB磷酸化增加,从而降解的假设。这反过来将增加NF κ B活化和考克斯-2表达。 2)确定E诱导老年初始T细胞功能增加的机制。为了实现这一目标,我们将测试的假设,E增强幼稚T细胞功能,在老年小鼠,通过增加他们的能力,形成一个有效的免疫突触的T细胞受体(TCR)和抗原接触的网站。反过来,这将导致老年小鼠中TCR相关信号转导的改善,以及随后的IL-2产生。我们提出,E通过改变膜脂质结构域(称为脂筏)中关键TCR相关信号分子的再分布来诱导其效应,其机制为以下一种或两种:a)增加与TCR介导的活化相关的关键信号分子的棕榈酰化,和B)改变脂筏的脂质组分的结构。 这些实验将阐明与年龄相关的巨噬细胞和T细胞失调的机制,以及它们被E。反过来,这将有助于设计实用的营养干预措施,以逆转和/或延迟与年龄相关的免疫和炎症反应失调以及与之相关的疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SIMIN Nikbin MEYDANI其他文献

SIMIN Nikbin MEYDANI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SIMIN Nikbin MEYDANI', 18)}}的其他基金

Zinc intervention in prevention of pneumonia in elderly
锌干预预防老年人肺炎
  • 批准号:
    10216609
  • 财政年份:
    2021
  • 资助金额:
    $ 28万
  • 项目类别:
Calorie Restriction and immune Response in Humans
人类的热量限制和免疫反应
  • 批准号:
    7596995
  • 财政年份:
    2007
  • 资助金额:
    $ 28万
  • 项目类别:
Calorie Restriction and immune Response in Humans
人类的热量限制和免疫反应
  • 批准号:
    8048976
  • 财政年份:
    2007
  • 资助金额:
    $ 28万
  • 项目类别:
Calorie Restriction and immune Response in Humans
人类的热量限制和免疫反应
  • 批准号:
    7244163
  • 财政年份:
    2007
  • 资助金额:
    $ 28万
  • 项目类别:
Age-related changes in the proteome and lipidome of the immunological synapse
免疫突触蛋白质组和脂质组与年龄相关的变化
  • 批准号:
    7332620
  • 财政年份:
    2007
  • 资助金额:
    $ 28万
  • 项目类别:
Calorie Restriction and immune Response in Humans
人类的热量限制和免疫反应
  • 批准号:
    7608792
  • 财政年份:
    2007
  • 资助金额:
    $ 28万
  • 项目类别:
Calorie Restriction and immune Response in Humans
人类的热量限制和免疫反应
  • 批准号:
    7404487
  • 财政年份:
    2007
  • 资助金额:
    $ 28万
  • 项目类别:
Age-related changes in the proteome and lipidome of the immunological synapse
免疫突触蛋白质组和脂质组与年龄相关的变化
  • 批准号:
    7483088
  • 财政年份:
    2007
  • 资助金额:
    $ 28万
  • 项目类别:
Calorie Restriction and immune Response in Humans
人类的热量限制和免疫反应
  • 批准号:
    7797528
  • 财政年份:
    2007
  • 资助金额:
    $ 28万
  • 项目类别:
Aging: Mechanism & Prevention: 35th Annual Meeting of AGE
老化:机制
  • 批准号:
    7114140
  • 财政年份:
    2006
  • 资助金额:
    $ 28万
  • 项目类别:

相似海外基金

Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23K28188
  • 财政年份:
    2024
  • 资助金额:
    $ 28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
  • 批准号:
    DP240102905
  • 财政年份:
    2024
  • 资助金额:
    $ 28万
  • 项目类别:
    Discovery Projects
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
  • 批准号:
    2339172
  • 财政年份:
    2024
  • 资助金额:
    $ 28万
  • 项目类别:
    Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
  • 批准号:
    10577518
  • 财政年份:
    2023
  • 资助金额:
    $ 28万
  • 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23H03498
  • 财政年份:
    2023
  • 资助金额:
    $ 28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
  • 批准号:
    10676407
  • 财政年份:
    2023
  • 资助金额:
    $ 28万
  • 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
  • 批准号:
    22KK0277
  • 财政年份:
    2023
  • 资助金额:
    $ 28万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
  • 批准号:
    10599584
  • 财政年份:
    2023
  • 资助金额:
    $ 28万
  • 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
  • 批准号:
    10530023
  • 财政年份:
    2022
  • 资助金额:
    $ 28万
  • 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
  • 批准号:
    10684172
  • 财政年份:
    2022
  • 资助金额:
    $ 28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了